Free Trial
OTCMKTS:RHHBY

Roche (RHHBY) Stock Price, News & Analysis

Roche logo
$39.27 -0.24 (-0.61%)
As of 04:00 PM Eastern

About Roche Stock (OTCMKTS:RHHBY)

Key Stats

Today's Range
$39.17
$39.48
50-Day Range
$35.90
$43.38
52-Week Range
$31.30
$44.31
Volume
632,332 shs
Average Volume
2.88 million shs
Market Capitalization
$250.46 billion
P/E Ratio
N/A
Dividend Yield
2.22%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Receive RHHBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

RHHBY Stock News Headlines

3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.
3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S. (RHHBY)
See these three top-10 stocks in the pharmaceutical industry that are pledging investment in the United States totalling over $100 billion.
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Tandem Diabetes, Roche enter patent settlement agreement
See More Headlines

RHHBY Stock Analysis - Frequently Asked Questions

Roche's stock was trading at $34.88 at the start of the year. Since then, RHHBY stock has increased by 12.6% and is now trading at $39.27.
View the best growth stocks for 2025 here
.

Roche subsidiaries include these companies: Inflazome, Stratos Genomics, Promedior, Spark Therapeutics, Tusk Therapeutics, Flatiron Health, Ignyta, and more.

Top institutional investors of Roche include GAMMA Investing LLC (0.01%), Boston Common Asset Management LLC (0.01%), OLD National Bancorp IN and Altrius Capital Management Inc.

Shares of RHHBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/28/2025
Next Earnings (Estimated)
7/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:RHHBY
CIK
N/A
Employees
103,605
Year Founded
1896

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
13.98
P/E Growth
2.18
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$68.73 billion
Cash Flow
$3.06 per share
Price / Cash Flow
12.82
Book Value
$5.81 per share
Price / Book
6.76

Miscellaneous

Outstanding Shares
6,377,936,000
Free Float
N/A
Market Cap
$250.46 billion
Optionable
Not Optionable
Beta
0.46

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (OTCMKTS:RHHBY) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners